Skip to content

A Study on the Effect of Vidangadi Dhoompan in Treating of kaphaj Pratishaya( chronic simple rhinitis)

A Clinical Study on the Efficacy of Vidangadi Dhoompan in the Management of Kaphaj Pratishaya with Special Reference to Chronic Simple Rhinitis - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105461
Enrollment
102
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

None listed

Sponsors

Dr.Gargee Someshwarrao Khairkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with classical signs and symptoms of KaphajaPratishyaya such as Nasa Strava ( thick, white, mucoid nasal discharge), Aruchi ( loss of appetite), Kaphotklesha ( sense of heaviness/discomfort due to Kapha), Shirashoola ( headache), Nasa Kandu ( nasal itching), post-nasal drip, nasal obstruction, and swollen turbinates will be included in the study. 2. Patients aged between 18 and 60 years, irrespective of gender, occupation, religion, or socioeconomic background. 3. Patients who are willing to participate in the study and have provided written informed consent. 4.Patients deemed fit for DhoompanKarma as per Ayurvedic criteria.

Exclusion criteria

Exclusion criteria: 1.Patients who do not meet the inclusion criteria. 2. Patients suffering from any serious systemic illness, such as cancer or tuberculosis. 3. Patients who are unwilling to undergo treatment or do not provide consent for participation. 4.Patients who develop any serious adverse event or medical complication during the study. 5.Pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
Reduction in severity of cardinal symptoms of Kaphaj Pratishyaya (Chronic Simple Rhinitis) (nasal obstruction, nasal discharge, sneezing, head heaviness) from baseline to end of treatment.Timepoint: Follow up on 0, 7, 14 and 21st day

Secondary

MeasureTime frame
Improvement in associated symptoms (post-nasal drip, hyposmia, headache). Reduction in nasal mucosal congestion/turbinate hypertrophy on anterior rhinoscopy. Improvement in quality of life.Timepoint: Follow up on 0, 7, 14 and 21st day

Countries

India

Contacts

Public ContactDr Gargee Someshwarrao Khairkar

Vidarbha Ayurveda Mahavidyalaya

Chaudharidevendra5@gmail.com8208501419

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026